SEC Form 4 · accession 0001209191-15-039174
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mitchell H. Finer
Officer — Chief Scientific Officer
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 8:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2015 | M | 815 | $2.0864 | A | 815 | D | |
| Common Stock | May 4, 2015 | M | 14,185 | $5.5004 | A | 15,000 | D | |
| Common StockF2 | May 4, 2015 | S | 6,886 | $131.269 | D | 8,114 | D | |
| Common StockF3 | May 4, 2015 | S | 5,124 | $131.9411 | D | 2,990 | D | |
| Common StockF4 | May 4, 2015 | S | 2,990 | $132.965 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $2.0864 | May 4, 2015 | M | 266 | D | — | Jul 13, 2021 | Common Stock | 266 | 3,188 | D |
| Stock Option (right to buy)F6 | $2.0864 | May 4, 2015 | M | 549 | D | — | Jun 4, 2022 | Common Stock | 549 | 6,591 | D |
| Stock Option (right to buy)F7 | $5.5004 | May 4, 2015 | M | 14,185 | D | — | Jan 16, 2023 | Common Stock | 14,185 | 130,550 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014.
- F2The range of prices for the transaction reported on this line was $130.50 to $131.50. The average weighted price was $131.2690. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $131.51 to $132.50. The average weighted price was $131.9411. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $132.75 to $133.27. The average weighted price was $132.9650. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5This option vests at a rate of twenty-five percent (25%) on April 15, 2012 and in 36 equal monthly installments thereafter.
- F6This option vests at a rate of twenty-five percent (25%) on May 1, 2013 and in 36 equal monthly installments thereafter.
- F7This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.